Phase III pivotal trial of a long-acting intramuscular injection of glatiramer acetate (GA Depot) in patients with multiple sclerosis.
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
- 31 Oct 2017 According to a Mapi Pharma media release, this trial is expected to initiate in 2018.
- 22 Dec 2014 New trial record